RxDoctor Payments DataLook up a doctor →

Tonya Phillips, MD

Neurology · Fort Smith, ARNPI 1952323297

Payments from drug & device makers

$16,706in general payments, 2019–2025

Across 1,041 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$2K
  • SK Life Science, Inc.$1K
  • UCB, Inc.$894
  • Pfizer$845
  • Biogen$818
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)140$2,531
Novartis117$1,921
SK Life Science, Inc.57$1,072
UCB, Inc.58$894
Pfizer59$845
Biogen47$818
Amgen41$787
Neurocrine Biosciences, Inc.45$709
Eisai Inc.39$619
Acadia Pharmaceuticals Inc26$450
Lundbeck LLC23$446
MDD US Operations, LLC18$388
Sanofi23$338
Amneal Pharmaceuticals LLC19$303
EMD Serono, Inc.26$302
Sunovion Pharmaceuticals Inc.25$298
AstraZeneca(2 entities)14$254
Biohaven Pharmaceutical Holding Company Ltd.28$245
Avanir Pharmaceuticals, Inc.18$226
Supernus Pharmaceuticals, Inc.52$214
GT Medical Technologies, Inc1$209
Lilly USA, LLC14$209
Argenx US, Inc.11$201
Teva Pharmaceuticals USA, Inc.12$195
Acorda Therapeutics, Inc10$189
Adamas Pharmaceuticals, Inc.14$172
Tanabe Pharma America, Inc.9$138
Meditrina1$129
Kyowa Kirin, Inc.8$124
Neurelis, Inc.7$113
Catalyst Pharmaceuticals, Inc.6$112
Genentech USA, Inc.6$96
Livanova USA, Inc.3$96
TELA Bio, Inc.1$81
Banner Life Sciences, LLC4$72
Biohaven Pharmaceuticals, Inc.5$70
Otsuka America Pharmaceutical, Inc.4$68
Takeda Pharmaceuticals U.S.A., Inc.8$64
Bristol Myers Squibb3$57
Upsher-smith Laboratories LLC3$54
ANI Pharmaceuticals, Inc.2$53
Mallinckrodt Enterprises LLC3$51
Averitas Pharma Inc.2$50
Jazz Pharmaceuticals Inc.3$47
Johnson & Johnson3$46
Grifols USA, LLC2$45
Merz Pharmaceuticals, LLC2$38
Corium, LLC4$38
Axsome Therapeutics, Inc.2$33
TG Therapeutics, Inc.1$33
Kedrion Biopharma, Inc.2$29
Vertical Pharmaceuticals, LLC1$27
Zyla Life Sciences, Inc.2$24
Arbor Pharmaceuticals, Inc.1$18
Avion Pharmaceuticals1$17
Abbott1$14
Alnylam Pharmaceuticals Inc.1$13
Greenwich Biosciences, Inc.1$13
GRT US Holding, Inc.1$7
Kinex Medical Company LLC1$2

How this compares

$16,706 in reported general payments places this provider in the 75th percentile of 93 neurology providers in Arkansas.

See all neurology providers in Arkansas

Medicare billing

Part B allowed, 2024
$172,768
Medicare patients
588
Services billed
11,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →